Stay Informed

Sign up for news & alerts

Already signed up?
Login here

take action
For every $1 states spend dollar sign on substance misuse and addiction, 94 cents go to shovel up the consequences instead of for treatment and prevention. TELL YOUR LEGISLATORS

What Can I Do?



Continuing Education
Free online courses for addiction counselors LEARN ONLINE

Get Help
Need alcohol or drug help for yourself or someone else? GET HELP

 
Britain Close to Approving Marijuana-Based Medicine
January 28, 2004

Share Share Email
Email
Print
Print
SubscribeSubscribe
News Summary

Britain's Home Office is expected to approve Sativex, a new marijuana-based drug used to ease severe pain, the New York Times reported Jan. 27.

GW Pharmaceuticals of Britain developed the drug, which is a liquid extract of marijuana grown by the company under license from the government.

In addition to containing THC, the active ingredient in marijuana, Sativex also includes significant levels of cannabinoid cannabidiol, believed to have anti-anxiety and other therapeutic properties, as well as dozens of other marijuana ingredients.

However, GW Pharmaceuticals said that when taken properly, Sativex does not give people the "high" normally associated with smoking marijuana.

Especially designed for people with multiple sclerosis or other conditions causing severe pain, Sativex would be marketed as a spray applied under the tongue.

Alan Macfarlane, a chief inspector at the Home Office, said the results of Sativex in clinical trials were encouraging. Of the drug's approval, he said, "I'm hoping it will be dealt with in the next two to three months, and I will be surprised if it doesn't succeed."

GW Pharmaceuticals also plans to seek regulatory approval from the U.S. Food and Drug Administration. However, given the government's policy against marijuana use, the review process could take longer than usual.

COMMENTS ON THIS ARTICLE:
(Comments now appear first to last)

Your Turn! Post a public comment (guidelines):

Name:

Comment:
(limit 250
words)
Enter this word
(help):		 Change

GUIDELINES: 
To keep this feature useful for everyone, please:

  1. Keep it clean, courteous, brief, and on-topic. Comments are for discussion of the above article, not general rants or manifestos. Serial comments intended to circumvent the 250-word limit may be deleted.

  2. Do not post promotional web links, personal information or requests for assistance (get help).

  3. Proof your comments carefully, use good spelling and punctuation, and don't use ALL CAPS. Comments are published immediately and cannot be edited.

Deceptive, slanderous and commercial posts are prohibited. We reserve the right to remove comments. (Report a comment).

Have questions or feedback? Contact us.